December 17, 2002 Meeting of the Science Advisory Board's Cancer Identification Committee (CIC)
Notice to Interested Parties December 17, 2002 Meeting of the Science Advisory Board's Cancer Identification Committee (CIC)
The California Environmental Protection Agency's Office of Environmental Health Hazard Assessment (OEHHA) is the lead agency for the implementation of the Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65).
The Carcinogen Identification Committee (CIC) of OEHHA's Science Advisory Board identifies chemicals for addition to the list of chemicals known to the State to cause cancer, which is mandated by Health and Safety Code Section 25249.8. The Committee serves as the "State's qualified experts" for determining whether a chemical has been clearly shown, through scientifically valid testing according to generally accepted principles, to cause cancer.
A public meeting of this committee will be held on Tuesday, December 17, 2002 at the California Environmental Protection Agency Headquarters Building, Coastal Hearing Room, at 1001 I Street, Sacramento, California, beginning at 10:00 a.m. and continuing until all business has been conducted, or 5:00 p.m.
OEHHA is committed to public participation and external scientific peer review in its efforts to implement Proposition 65. OEHHA welcomes public input on any of the agenda items identified below. The Committee prefers that information for its consideration be presented in writing prior to its meetings so that it can give due consideration to the material and so that it can devote time at the meetings to discussion and clarification, rather than to extensive oral testimony. The public comment period for the draft hazard identification document on phenelzine and its acid salts will close on November 19, 2002. Written comments on the draft hazard identification document on sodium saccharin and the other agenda items should be submitted by December 10, 2002, to the Proposition 65 Office, Proposition 65 Implementation Office, 1001 I Street, 19th floor, Sacramento, California, 95814 or P.O. Box 4010, Sacramento, California, 95812-4010. Oral comments may be made to the Committee at the meeting on December 17, 2002.
The draft documents describing the "Evidence on the Carcinogenicity of Phenelzine and its Acid Salts" and "Evidence on the Carcinogenicity of Sodium Saccharin," are available from the Proposition 65 Implementation Office at (916) 445-6900 or from the downloads section below. Copies of the materials related to the request for Committee review of statin drugs as a group for subsequent listing consideration are also available from the Proposition 65 Implementation Office or from the hyperlinks provided.
The order in which the Committee takes up items is subject to change at the discretion of the Chair. The tentative agenda for this meeting is as follows:
I. INTRODUCTION OF AND ADMINISTRATION OF THE OATH OF OFFICE TO NEWLY APPOINTED MEMBERS
II. CONSIDERATION OF A CHEMICAL AS KNOWN TO THE STATE TO CAUSE CANCER
- Staff presentation
- Committee discussion
- Public comments
- Committee discussion and decision
III. CONSIDERATION OF A CHEMICAL, LISTED VIA THE STATE'S QUALIFIED EXPERTS MECHANISM, FOR POSSIBLE REMOVAL FROM THE LIST
- Staff presentation
- Committee discussion
- Public comments
- Committee discussion and decision
IV. CONSIDERATION OF REQUEST TO REVIEW STATIN DRUGS AS A GROUP FOR SUBSEQUENT LISTING CONSIDERATION
- Staff briefing of request
- Public comments
- Committee discussion and decision
VI. STAFF REPORTS
- A. Status of chemical listings via the administrative listing mechanisms
- B. Proposition 65 litigation and rulings
- C. Public comment
VII. SUMMARY OF COMMITTEE ACTIONS
- Lovastatin
- Pravastatin sodium
- Simvastatin
- Phenelzine and its acid salts
- Atorvastatin calcium
- Fluvastatin sodium
- Sodium Saccharin
- Cerivastatin sodium